- Home
- BENF vs QNRX Comparison
BENF vs QNRX Comparison
Compare BENF & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BENF
- QNRX
- Stock Information
- Founded
- BENF 2003
- QNRX 2018
- Country
- BENF United States
- QNRX United States
- Employees
- BENF N/A
- QNRX N/A
- Industry
- BENF Blank Checks
- QNRX Medical/Dental Instruments
- Sector
- BENF Finance
- QNRX Health Care
- Exchange
- BENF Nasdaq
- QNRX Nasdaq
- Market Cap
- BENF 2.8M
- QNRX 3.3M
- IPO Year
- BENF N/A
- QNRX N/A
- Fundamental
- Price
- BENF $0.28
- QNRX $8.70
- Analyst Decision
- BENF
- QNRX
- Analyst Count
- BENF 0
- QNRX 0
- Target Price
- BENF N/A
- QNRX N/A
- AVG Volume (30 Days)
- BENF 2.6M
- QNRX 21.0K
- Earning Date
- BENF 08-13-2025
- QNRX 08-07-2025
- Dividend Yield
- BENF N/A
- QNRX N/A
- EPS Growth
- BENF N/A
- QNRX N/A
- EPS
- BENF N/A
- QNRX N/A
- Revenue
- BENF N/A
- QNRX N/A
- Revenue This Year
- BENF N/A
- QNRX N/A
- Revenue Next Year
- BENF N/A
- QNRX N/A
- P/E Ratio
- BENF N/A
- QNRX N/A
- Revenue Growth
- BENF N/A
- QNRX N/A
- 52 Week Low
- BENF $0.22
- QNRX $5.01
- 52 Week High
- BENF $6.27
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- BENF 42.56
- QNRX 56.56
- Support Level
- BENF $0.28
- QNRX $8.00
- Resistance Level
- BENF $0.31
- QNRX $8.58
- Average True Range (ATR)
- BENF 0.04
- QNRX 0.44
- MACD
- BENF -0.00
- QNRX -0.08
- Stochastic Oscillator
- BENF 7.20
- QNRX 53.85
About BENF Beneficient
Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.